August 15, 2022—End-to-end drug development company Praedicare has found promise in a potential treatment for listeriosis using Crestone’s antibacterial drug candidate CRS0540. Read more about these exciting findings in the press release below, published on Cision PR Newswire’s website:

https://www.prnewswire.com/news-releases/crestone-inc-and-praedicare-inc-announce-the-publication-of-data-on-the-novel-antibiotic-crs0540-in-the-hollow-fiber-system-model-of-the-orphan-disease-disseminated-listeriosis-301606053.html